Acrivon Therapeutics (ACRV)

Profile

Full Name

Acrivon Therapeutics, Inc.

Ticker Symbol

ACRV

Exchange

NASDAQ

Sector

Healthcare

Industry

Biotechnology

Country

United States

IPO

November 15, 2022

Indexes

Not included

Website

http://www.acrivon.com

Employees

75

Key Details

Price

$2.15(+43.33%)

Market cap

Last Dividend

-

TTM Dividend yield

-

Annual revenue

-

Annual EPS

-$2.38(+13.14% YoY)

PE ratio

-

Next earnings date

May 14, 2025

Next ex-dividend date

N/A

Next split date

N/A

Price

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Current Price

$2.15
ACRV price is $2.15

30-Day Relative Volume

6.03
ACRV 30-day relative volume is 6.03

Price Performance

Price Most recent change

+43.33%
ACRV price was up +43.33% on Apr 15, 2025

Price YTD change

-64.29%
ACRV price is down -64.29% since January 1st

Price 1-year change

-77.63%
ACRV price is down -77.63% year-on-year

Price 3-year change

-
ACRV price 3-year change is unknown

Price Range

Price All-time high

$25.47
ACRV price is currently -91.56% below its historical high of $25.47

Price 3-year low

$1.30
ACRV price is currently +65.38% above its 3-year low

Capitalization

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Market cap

Market cap

$67.41M
ACRV market capitalization is $67.41 million

Market cap 3-year change

-
ACRV market capitalization 3-year change is unknown

Market cap All-time high

$508.55M
ACRV market capitalization is currently -86.75% below its historical high of $508.55 million

Market cap sector rank

42.52%
ACRV market capitalization is higher than 42.52% of companies in Healthcare sector

Shares Outstanding

Shares Outstanding 1-Year Change

+1.55%
ACRV shares outstanding is up +1.55% year-on-year

Shares Outstanding 3-Year Change

-
ACRV shares outstanding 3-year change is unknown

Technical Indicators

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Beta

1.84
ACRV beta is 1.84

200-day SMA

$6.58
ACRV price is currently -67.33% below its 200-day simple moving average

50-day SMA

$4.39
ACRV price is currently -51.00% below its 50-day simple moving average

RSI

38.15
ACRV 14-day relative strength index is 38.15

Volume

6.03
ACRV 30-day relative volume is 6.03

ATR

$0.39
ACRV average true range is $0.39

10-day Historical Volatility

258.34%
ACRV 10-day historical volatility is 258.34%

Dividend

Income Statement

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Revenue

Revenue

-
ACRV annual revenue value is unknown

Revenue Analysts estimate

$129.33K
ACRV annual revenue is currently equal to the consensus analysts' forecast

Revenue 1-year change

-
ACRV annual revenue 1-year change is unknown

Revenue Sector rank

-
ACRV annual revenue is unknown

EPS

EPS

-$2.38
ACRV annual earnings per share is -$2.38

EPS Analysts estimate

-$2.64
ACRV annual earnings per share is currently -9.74% lower than the consensus analysts' forecast

EPS 1-year change

+13.14%
ACRV annual earnings per share is up +13.14% year-on-year

EPS Sector rank

34.88%
ACRV annual earnings per share is higher than 34.88% of companies in Healthcare sector

Profit

Gross profit

-
ACRV annual gross profit value is unknown

Gross margin

-
ACRV annual gross profit margin value is unknown

Operating profit

-$89.20M
ACRV annual operating income is -$89.20 million

Operating margin

-
ACRV annual operating profit margin value is unknown

Net income

-$80.56M
ACRV annual net profit is -$80.56 million

Net margin

-
ACRV annual net profit margin value is unknown

Expenses

Total expenses

$89.20M
ACRV annual total expenses is $89.20 million

Operating expenses

$89.20M
ACRV annual total operating expenses is $89.20 million

Cost of goods sold

-
ACRV annual cost of goods sold value is unknown

Selling, general & administrative expenses

$25.21M
ACRV annual SGA is $25.21 million

Depreciation and amortization

$1.01M
ACRV annual depreciation & amortization is $1.01 million

Interest expense

-
ACRV annual interest expense value is unknown

Income tax

-
ACRV annual income tax value is unknown

EBIT & EBITDA

EBIT

-$89.20M
ACRV annual earnings before interest & taxes is -$89.20 million

EBITDA

-$88.19M
ACRV annual EBITDA is -$88.19 million

Balance Sheet

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Assets

Total assets

$196.59M
ACRV annual total assets is $196.59 million

Non current assets

$14.96M
ACRV annual long term assets is $14.96 million

Current assets

$181.63M
ACRV annual total current assets is $181.63 million

Cash and cash equivalents

$39.82M
ACRV annual cash & cash equivalents is $39.82 million

Accounts receivable

-
ACRV annual accounts receivable value is unknown

Inventory

-
ACRV annual inventory value is unknown

Liabilities

Total liabilities

$19.80M
ACRV annual total liabilities is $19.80 million

Long term liabilities

$2.59M
ACRV annual total long term liabilities is $2.59 million

Current liabilities

$17.21M
ACRV annual total current liabilities is $17.21 million

Accounts payable

$758.00K
ACRV annual accounts payable is $758.00 thousand

Debt

Total debt

$3.65M
ACRV annual total debt is $3.65 million

Total debt 1-year change

-21.51%
ACRV annual total debt is down -21.51% year-on-year

Long term debt

$2.59M
ACRV annual long term debt is $2.59 million

Short term debt

$1.06M
ACRV annual short term debt is $1.06 million

Equity & Capital

Shareholders equity

$176.79M
ACRV annual stockholders equity is $176.79 million

Book value

$176.79M
ACRV annual book value is $176.79 million

Retained earnings

-$196.98M
ACRV annual retained earnings is -$196.98 million

Working capital

$164.41M
ACRV annual working capital is $164.41 million

Cash Flow Statement

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Cashflow Activities

Cash from operations

-$65.67M
ACRV annual cash flow from operations is -$65.67 million

Cash from operations 1-year change

-54%
ACRV annual cash flow from operations is down -54% year-on-year

Cash from investing

-$51.77M
ACRV annual cash flow from investing activities is -$51.77 million

Cash from investing 1-year change

-202.08%
ACRV annual cash flow from investing activities is down -202.08% year-on-year

Cash from financing

$121.03M
ACRV annual cash flow from financing activities is $121.03 million

Cash from financing 1-year change

+7888.1%
ACRV annual cash flow from financing activities is up +7888.1% year-on-year

CAPEX

CAPEX

-
ACRV annual capital expenditures value is unknown

CAPEX 1-year change

-
ACRV annual capital expenditures 1-year change is unknown

Free Cash Flow

Free cash flow

-$68.44M
ACRV annual free cash flow is -$68.44 million

Free cash flow 1-year change

-55.79%
ACRV annual free cash flow is down -55.79% year-on-year

Profitability Ratios

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Margins

Gross margin

-
ACRV annual gross profit margin value is unknown

Operating margin

-
ACRV annual operating profit margin value is unknown

Net margin

-
ACRV annual net profit margin value is unknown

ROA & ROE

ROA

-40.98%
ACRV annual return on assets is -40.98%

ROE

-45.57%
ACRV annual return on equity is -45.57%

Valuation

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

PE Ratio

PE ratio

-
ACRV price to earnings ratio value is unknown

PE ratio Sector rank

-
ACRV price to earnings ratio is unknown

PB Ratio

PB ratio

0.38
ACRV price to book ratio is 0.38

PB ratio Sector rank

26.26%
ACRV price to book ratio is higher than 26.26% of companies in Healthcare sector

PS Ratio

PS ratio

-
ACRV price to sales ratio value is unknown

PS ratio Sector rank

-
ACRV price to sales ratio is unknown

Enterprise value

Enterprise value

$31.23M
ACRV enterprise value is $31.23 million

Enterprise value Sector rank

35.65%
ACRV enterprise value is higher than 35.65% of companies in Healthcare sector

EV/EBITDA

EV/EBITDA

-0.35
ACRV EV/EBITDA is -0.35

EV/EBITDA Sector rank

54.74%
ACRV EV/EBITDA is higher than 54.74% of companies in Healthcare sector

Financial Health

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Liquidity

Current ratio

10.55
ACRV annual current ratio is 10.55

Quick ratio

-
ACRV annual quick ratio value is unknown

Leverage

Debt to equity

0.02
ACRV annual debt to equity ratio is 0.02

Interest coverage ratio

-
ACRV annual interest coverage ratio value is unknown

Risk & Stability

Piotroski F-Score

-
ACRV piotroski f-score value is unknown

Altman Z-Score

-
ACRV altman z-score value is unknown

Analyst ratings

Recent major analysts updates

Mar 28, 25 HC Wainwright & Co.
Buy
Mar 26, 25 HC Wainwright & Co.
Buy
Mar 26, 25 Citizens Capital Markets
Market Outperform
Mar 26, 25 Cantor Fitzgerald
Overweight
Jan 31, 25 Cantor Fitzgerald
Overweight
Nov 14, 24 HC Wainwright& Co.
Buy
Nov 14, 24 HC Wainwright & Co.
Buy
Nov 14, 24 BMO Capital
Outperform
Sep 16, 24 Ladenburg Thalmann
Buy
Sep 16, 24 JMP Securities
Market Outperform

Institutional Ownership

Similar stocks

ADVM logo
Adverum Biotechnologies (ADVM)
MNOV logo
MediciNova (MNOV)
SAVA logo
Cassava Sciences (SAVA)
ICCM logo
IceCure Medical Ltd (ICCM)
YI logo
111 (YI)
FORA logo
Forian (FORA)
BMEA logo
Biomea Fusion (BMEA)
Sagimet Biosciences (SGMT)
GNTA logo
Genenta Science SpA (GNTA)
  • What is the ticker symbol for Acrivon Therapeutics?
  • Does Acrivon Therapeutics pay dividends?
  • What sector is Acrivon Therapeutics in?
  • What industry is Acrivon Therapeutics in?
  • What country is Acrivon Therapeutics based in?
  • When did Acrivon Therapeutics go public?
  • Is Acrivon Therapeutics in the S&P 500?
  • Is Acrivon Therapeutics in the NASDAQ 100?
  • Is Acrivon Therapeutics in the Dow Jones?
  • When was Acrivon Therapeutics's last earnings report?
  • When does Acrivon Therapeutics report earnings?
  • Should I buy Acrivon Therapeutics stock now?

What is the ticker symbol for Acrivon Therapeutics?

The ticker symbol for Acrivon Therapeutics is NASDAQ:ACRV

Does Acrivon Therapeutics pay dividends?

No, Acrivon Therapeutics does not pay dividends

What sector is Acrivon Therapeutics in?

Acrivon Therapeutics is in the Healthcare sector

What industry is Acrivon Therapeutics in?

Acrivon Therapeutics is in the Biotechnology industry

What country is Acrivon Therapeutics based in?

Acrivon Therapeutics is headquartered in United States

When did Acrivon Therapeutics go public?

Acrivon Therapeutics's initial public offering (IPO) was on November 15, 2022

Is Acrivon Therapeutics in the S&P 500?

No, Acrivon Therapeutics is not included in the S&P 500 index

Is Acrivon Therapeutics in the NASDAQ 100?

No, Acrivon Therapeutics is not included in the NASDAQ 100 index

Is Acrivon Therapeutics in the Dow Jones?

No, Acrivon Therapeutics is not included in the Dow Jones index

When was Acrivon Therapeutics's last earnings report?

Acrivon Therapeutics's most recent earnings report was on Mar 27, 2025

When does Acrivon Therapeutics report earnings?

The next expected earnings date for Acrivon Therapeutics is May 14, 2025

Should I buy Acrivon Therapeutics stock now?

As of today, analysts generally recommend a 'Strong buy' rating. However, it's important to do your own research and consider your financial situation before making any investment decisions
On this page